New Method To Create Artificial Organs-greatly reduce complications and risk of rejection

Spanish researchers unveiled a new method to create bioartifical organs for patients having theirs fail using stem cells. Scientist claim this will greatly reduce complications of the organ being donated. In American more than 98,000 people are on the wait … Continue reading

Bookmark and Share

Transform Adult Cells into Embryonic State: Induced pluripotent stem cells

Induced pluripotent stem cells, commonly abbreviated as iPS cells or iPSCs are a type of pluripotent stem cell artificially derived from a non-pluripotent cell, typically an adult somatic cell, by inducing a “forced” expression of specific genes. Induced Pluripotent Stem … Continue reading

Bookmark and Share

Bioprinting and Tissue Engineering: The Future of Organ Transplants

Bioprinting and Tissue Engineering: The Future of Organ Transplants William Browning, Yahoo! Contributor Network Bioprinting is a relatively new form of technology whereby biological cells are heaped upon each other in a specific pattern much in the same way many … Continue reading

Bookmark and Share

Parthenogenesis: a new paradigm for regenerative and stem cell therapy?

Parthenogenesis is a form of asexual reproduction found in females, where growth and development of embryos occurs without fertilization by a male. In plants, parthenogenesis means development of an embryo from an unfertilized egg cell, and is a component process … Continue reading

Bookmark and Share

Tissue engineering and cell based therapies from the bench to the clinic: The potential to replace, repair and regenerate

Tissue engineering and cell based therapies from the bench to the clinic: The potential to replace, repair and regenerate Reprod Biol Endocrinol. 2003; 1: 102. William L Fodor The field of Regenerative Biology as it applies to Regenerative Medicine is … Continue reading

Bookmark and Share

ProSavin®, a gene-based treatment for Parkinson’s disease, Performs Well in Parkinson’s Trial

Parkinson’s disease currently affects 4.1 million patients globally which is projected to rise to 8.7 million by 2030.  A patient with Parkinson’s disease progressively loses the ability to make the neurotransmitter dopamine, the mediator of the control of movement.  There … Continue reading

Bookmark and Share